Late-night cravings aren’t the only thing DoorDash can help with.
Starting this week, women can order a first-of-its-kind, at-home swab test for three common sexually transmitted infections and have it delivered straight to their door.
The Visby Medical test is said to produce lab-accurate results in just 30 minutes — no doctors, long waits or awkward small talk required.
“This is a true PCR test, the same diagnostic accuracy they’d get in a clinical setting and the same gold-standard molecular technology used in hospitals and laboratories — now available at home,” Adam de la Zerda, CEO and founder of Visby, told The Post.
“Quick, private access to testing helps people take responsibility for their health sooner and prevents long-term harm — that benefits everyone.”
Here’s how it works: Customers place an order for the $149.99 test, capable of screening for chlamydia, gonorrhea and trichomoniasis, on the Visby website, which guides them to the best delivery option.
In addition to DoorDash, the company has partnered with GoPuff to offer same-day delivery in 10 major cities, including New York, San Francisco and Las Vegas.
“It’s about meeting people where they are quickly, not asking them to navigate a complex healthcare system for something that should and can be simple and private,” de la Zerda said.
Once in hand, women collect a vaginal swab, insert the sample into the device and get results within 30 minutes through the Visby app.
“That’s a huge difference from typical home collection kits, which rely on mailing samples and waiting days for results,” de la Zerda said.
If the test comes back positive, the results can be sent through the app to a licensed, third-party telehealth provider, who can prescribe antibiotics to treat the infection immediately.
Across the country, more than 9 million women are diagnosed with STIs every year, though experts believe the true number is likely much higher.
“STIs are extremely common,” de la Zerda said. “You can do everything ‘right’ and still be exposed.”
Many infections go unnoticed because they are asymptomatic. In fact, up to 80% of chlamydia cases have no symptoms, meaning infections can spread even when someone feels fine.
Left untreated, these infections can cause serious complications in women, including infertility, chronic pelvic pain and even life-threatening ectopic pregnancies.
Traditional STI testing can cost $250 or more without insurance, depending on the provider and the number of tests needed.
“The faster someone can get tested and treated, the less chance there is for complications or further transmission,” de la Zerda said.
“But right now, many people delay testing because of inconvenience, privacy concerns or the logistics of booking an appointment.”
De la Zerda said Visby aims to remove those barriers. The test is eligible for FSA and HSA accounts.
“This is about giving people control over their own health, on their own terms,” he said. “The same way we have at-home tests for COVID or flu, we should have them for STIs.”
Visby recommends that women consider STI testing if they experience changes in vaginal discharge, bleeding between periods or pain during sex or urination.
The company also advises testing for anyone with a new or multiple sexual partners or anyone who suspects they may have been exposed to an STI.
